Cleared Traditional

K872629 - TAKEDA MEDICAL DIGITAL SPHYGMOMANOMETER...

K872629 is the FDA 510(k) clearance for TAKEDA MEDICAL DIGITAL SPHYGMOMANOMETER... by A&D Engineering, Inc.. It is a Class 2 Cardiovascular device (product code DXN) cleared through the Traditional 510(k) pathway after a 71-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 1987
Decision
71d
Days
Class 2
Risk

K872629 is an FDA 510(k) clearance for the TAKEDA MEDICAL DIGITAL SPHYGMOMANOMETER/ UA-741. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by A&D Engineering, Inc. (San Jose, US). The FDA issued a Cleared decision on September 15, 1987 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all A&D Engineering, Inc. devices

Submission Details

510(k) Number K872629 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 06, 1987
Decision Date September 15, 1987
Days to Decision 71 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 125d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 516
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K872629.
PYTHON AMBULATORY BLOOD PRESSURE MONITORING SYSTEM
K874917 · Oxford Medilog, Inc. · May 1988
OHMEDA 2350 FINAPRES(R) BLOOD PRESSURE MONITOR
K880572 · Ohmeda Medical · May 1988
DINAMAP VITAL SIGNS MONITOR, MODEL 8100T
K874378 · Critikon Company, LLC · Dec 1987
VITALNET(TM) SYSTEM (DINAMAP(TM), MODEL 2200)
K871418 · Critikon Company, LLC · Jul 1987
MODIFIED SPHYGMOMED NON-INVASIVE BLOOD PRES. MONIT
K871886 · Draeger Medical, Inc. · Jul 1987
SUPERMON NON-INVASIVE BLOOD PRESSURE MODULE 7282
K861374 · Kontron Instruments, Inc. · Jul 1987